Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05667324 · ClinicalTrials.gov registry record · Phase 4
Septorhinoplasty Post-operative Pain Control With SPG Nerve Block
A Phase 4 study of Deviated Nasal Septum, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05667324 is a Phase 4 study of Deviated Nasal Septum that has completed, run by University of Florida. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05667324, a Phase 4 study of Deviated Nasal Septum, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dexamethasone
- DRUG Ropivacaine
Study Locations (1)
Florida
- UF Health of University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2025-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05667324
The ClinicalTrials.gov registry entry for NCT05667324 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Deviated Nasal Septum appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05667324 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05667324 about?
NCT05667324 is a clinical study titled "Septorhinoplasty Post-operative Pain Control With SPG Nerve Block". Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach du...
What is the current status of trial NCT05667324?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2023-04-12. Estimated completion is 2025-02-28.
What conditions does trial NCT05667324 study?
This clinical trial studies the following conditions: Deviated Nasal Septum.
What interventions are being tested in trial NCT05667324?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT05667324?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05667324 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deviated Nasal Septum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.